兔抗KIR3DL1多克隆抗體

Background:

Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response.

Applications:

ELISA, WB, IHC

Name of antibody:

KIR3DL1

Immunogen:

Fusion protein of human KIR3DL1

Full name:

killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1

Synonyms:

KIR; NKB1; NKAT3; NKB1B; NKAT-3; CD158E1; KIR3DL1/S1

SwissProt:

P43629

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human liver cancer and Human tonsil

IHC Recommend dilution:

50-300

WB Predicted band size:

49 kDa

WB Positive control:

Human fetal liver tissue and Human liver tissue lysates

WB Recommended dilution:

1000-5000